These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37296918)

  • 21. Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial.
    Puviani M; Galloni C; Marchetti S; Sergio Pavone P; Lovati S; Pistone G; Caputo V; Tilotta G; Scarcella G; Campione E; Diluvio L; Garofalo V; Bianchi L; Milani M
    Curr Med Res Opin; 2017 Jul; 33(7):1255-1259. PubMed ID: 28358282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial.
    Samorano LP; Torezan LA; Sanches JA
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1822-7. PubMed ID: 25727104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
    Tanghetti E; Werschler P
    J Drugs Dermatol; 2007 Feb; 6(2):144-7. PubMed ID: 17373172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients.
    Nazzaro G; Carugno A; Bortoluzzi P; Buffon S; Astrua C; Zappia E; Trovato E; Caccavale S; Pellegrino V; Paolino G; Balestri R; Lacava R; Ciccarese G; Verdelli A; Barruscotti S; Valenti M; Toni G; Giacalone S; Zavattaro E; Gironi LC; Mercuri SR; Ribero S; Gisondi P; Sena P; Marzano AV
    Int J Dermatol; 2024 Nov; 63(11):1566-1574. PubMed ID: 38605473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
    Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
    Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
    Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
    J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index.
    Dirschka T; Pellacani G; Micali G; Malvehy J; Stratigos AJ; Casari A; Schmitz L; Gupta G;
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1295-1302. PubMed ID: 28401585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial.
    Salehi Farid A; Niknam S; Gholami K; Tavakolpour S; Teimourpour A; Daneshpazhooh M; Nili A; Azizpour A; Nasimi M; Mahmoudi H
    J Dermatolog Treat; 2022 May; 33(3):1376-1382. PubMed ID: 32875946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: A Randomized Placebo-Controlled Trial.
    Stoddard M; Herrmann J; Moy L; Moy R
    J Drugs Dermatol; 2017 Oct; 16(10):1030-1034. PubMed ID: 29036257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment.
    Jury CS; Ramraka-Jones VS; Gudi V; Herd RM
    Br J Dermatol; 2005 Oct; 153(4):808-10. PubMed ID: 16181465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-Term Follow-Up of a Randomized Controlled Trial of 0.5% and 5% 5-Fluorouracil After Microneedling for Treatment of Facial Actinic Keratoses.
    Kalil CLPV; Reinehr CPH; Bakos RM
    Dermatol Surg; 2022 Mar; 48(3):293-298. PubMed ID: 35125436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.
    Malvehy J; Alarcon I; Montoya J; Rodríguez-Azeredo R; Puig S
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):258-65. PubMed ID: 26538346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A feasibility study of microwave therapy for precancerous actinic keratosis.
    Jackson DN; Hogarth FJ; Sutherland D; Holmes EM; Donnan PT; Proby CM
    Br J Dermatol; 2020 Aug; 183(2):222-230. PubMed ID: 32030723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.
    Witheiler DD; Lawrence N; Cox SE; Cruz C; Cockerell CJ; Freemen RG
    Dermatol Surg; 1997 Mar; 23(3):191-6. PubMed ID: 9145962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italian expert consensus paper on the management of patients with actinic keratoses.
    Moscarella E; Di Brizzi EV; Casari A; De Giorgi V; Di Meo N; Fargnoli MC; Lacarrubba F; Micali G; Pellacani G; Peris K; Piaserico S; Calzavara-Pinton P; Quaglino P; Sollena P; Zalaudek I; Zane C; Argenziano G
    Dermatol Ther; 2020 Nov; 33(6):e13992. PubMed ID: 32648324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.
    Schmitz L; Gupta G; Segert MH; Kost R; Sternberg J; Gambichler T; Stockfleth E; Dirschka T
    Skin Pharmacol Physiol; 2018; 31(4):206-211. PubMed ID: 29791916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.
    Loven K; Stein L; Furst K; Levy S
    Clin Ther; 2002 Jun; 24(6):990-1000. PubMed ID: 12117087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
    Krawtchenko N; Roewert-Huber J; Ulrich M; Mann I; Sterry W; Stockfleth E
    Br J Dermatol; 2007 Dec; 157 Suppl 2():34-40. PubMed ID: 18067630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
    Nguyen HP; Rivers JK
    Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.